A Kaplan–Meier survival analysis revealed that factors such as differentiation grade, tumor size, TNM classification, T stage, N stage, M stage, and serum HIF1A-AS1 levels were all associated with the prognosis of CRC patients (all p < 0.05). The gene discussed is HIF1A; the disease is colorectal carcinoma.